Abraham Thomas

This inventor holds 31 USPTO granted patents and 3 published patent applications and 11 EPO patents, primarily in ROR Gamma Modulation. Top assignees: Glenmark Pharmaceuticals S.a., Glenmark Pharmaceuticals Limited. Active years: 2007-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abraham Thomas. Retrieved from https://idiyas.com/inventor/abraham-thomas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 3)

% Patents Active = 29.0

EPO Patents = 11 (Patent Applications = 8)

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 57(Granted Patents)

Location History:

Sanpada, IN (2013)
Navi Mumbai, IN (2007 - 2017)
Maharashtra, IN (2012 - 2021)

Company Filing History:

30 out of 65

Glenmark Pharmaceuticals S.a.

patents

1 out of 33

Glenmark Pharmaceuticals Limited

patents

Years Active: 2007-2021

Loading Chart...

Areas of Expertise:

ROR Gamma Modulators

TRPA1 Antagonists

DPP IV Inhibitors

Carbocyclic Compounds

Aryl Compounds

Fused Pyrimidine Derivatives

Pharmaceutical Composition

Chromane Derivatives

Bicyclic Heteroaryl

Thienopyrimidinedione Derivatives

Amides

2-Amino-4-Arylthiazole

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988467 - Compounds as ROR gamma modulators (2021-04-27),

2. 10344024 - Compounds as ROR gamma modulators (2019-07-09),

3. 10336688 - Carbocyclic compounds as ROR gamma modulators (2019-07-02),

4. 10189775 - Carbocyclic compounds as ROR gamma modulators (2019-01-29),

5. 9975887 - Compounds as ROR gamma modulators (2018-05-22),

6. 9718817 - Aryl and heteroaryl ether compounds as ROR gamma modulators (2017-08-01),

7. 9682977 - Bicyclic heteroaryl indole analogues useful as ROR gamma modulators (2017-06-20),

8. 9474758 - Thienopyrimidinedione derivatives as TRPA1 modulators (2016-10-25),

9. 9458173 - Amides of 2-amino-4-arylthiazole compounds and their salts (2016-10-04),

10. 9186360 - Treatment of respiratory disorders using TRPA1 antagonists (2015-11-17),

11. 9073955 - 2-amino-4-arylthiazole compounds as TRPA1 antagonists (2015-07-07),

12. 9000159 - Fused pyrimidine-dione derivatives as TRPA1 modulators (2015-04-07),

13. 8987278 - Thienopyrimidinedione derivatives as TRPA1 modulators (2015-03-24),

14. 8889862 - 2-amino-4-arylthiazole compounds as TRPA1 antagonists (2014-11-18),

15. 8623880 - Fused pyrimidine-dione derivatives as TRPA1 modulators (2014-01-07),

Title: The Innovative Journey of Abraham Thomas

Introduction: Abraham Thomas, a visionary inventor hailing from Navi Mumbai, India, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Abraham Thomas holds several patents in the areas of renewable energy, sustainable agriculture, and healthcare technology, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a background in engineering and a passion for problem-solving, Abraham Thomas has had a successful career marked by the development of cutting-edge solutions that have positively impacted various industries.

Collaborations: Throughout his career, Abraham Thomas has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to market, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Abraham Thomas stands as a shining example of an inventor who has not only pushed the boundaries of innovation but has also made a lasting impact on society through his dedication to creating solutions that address real-world challenges.

Profile summary based on public USPTO records.